BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31374052)

  • 1. Prognostic and clinicopathologic significance of MicroRNA-125a-5p in cancers: A meta-analysis.
    Ye H; Zhu W; Mei L; Lu Z
    Medicine (Baltimore); 2019 Aug; 98(31):e16685. PubMed ID: 31374052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab.
    Nishida N; Mimori K; Fabbri M; Yokobori T; Sudo T; Tanaka F; Shibata K; Ishii H; Doki Y; Mori M
    Clin Cancer Res; 2011 May; 17(9):2725-33. PubMed ID: 21220473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.
    Hashiguchi Y; Nishida N; Mimori K; Sudo T; Tanaka F; Shibata K; Ishii H; Mochizuki H; Hase K; Doki Y; Mori M
    Int J Oncol; 2012 May; 40(5):1477-82. PubMed ID: 22322911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells.
    Jiang L; Huang Q; Zhang S; Zhang Q; Chang J; Qiu X; Wang E
    BMC Cancer; 2010 Jun; 10():318. PubMed ID: 20569443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer.
    Vo DT; Karanam NK; Ding L; Saha D; Yordy JS; Giri U; Heymach JV; Story MD
    Neoplasia; 2019 Sep; 21(9):849-862. PubMed ID: 31325708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-125a-5p is a prognostic biomarker that targets HDAC4 to suppress breast tumorigenesis.
    Hsieh TH; Hsu CY; Tsai CF; Long CY; Chai CY; Hou MF; Lee JN; Wu DC; Wang SC; Tsai EM
    Oncotarget; 2015 Jan; 6(1):494-509. PubMed ID: 25504437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and clinicopathological significance of MicroRNA-153 in human cancers: A meta-analysis.
    Huang M; Li C; Kong F; Wu Y; Yuan Q; Hu L
    Medicine (Baltimore); 2020 Nov; 99(46):e22833. PubMed ID: 33181653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-125a-5p plays a role as a tumor suppressor in lung carcinoma cells by directly targeting STAT3.
    Zhong L; Sun S; Shi J; Cao F; Han X; Chen Z
    Tumour Biol; 2017 Jun; 39(6):1010428317697579. PubMed ID: 28631574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-125a-5p inhibits invasion and metastasis of gastric cancer cells by targeting BRMS1 expression.
    Cao Y; Tan S; Tu Y; Zhang G; Liu Y; Li D; Xu S; Le Z; Xiong J; Zou W; Gong P; Li Z; Jie Z
    Oncol Lett; 2018 Apr; 15(4):5119-5130. PubMed ID: 29552146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value and Clinicopathology Significance of MicroRNA-200c Expression in Cancer: A Meta-Analysis.
    Wu J; Fang Z; Xu J; Zhu W; Li Y; Yu Y
    PLoS One; 2015; 10(6):e0128642. PubMed ID: 26035744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-125a-5p expression is associated with the age of breast cancer patients.
    He H; Xu F; Huang W; Luo SY; Lin YT; Zhang GH; Du Q; Duan RH
    Genet Mol Res; 2015 Dec; 14(4):17927-33. PubMed ID: 26782438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic potential of TSTA3 in breast cancer and its regulation by the tumor suppressors miR-125a-5p and miR-125b.
    Sun Y; Liu X; Zhang Q; Mao X; Feng L; Su P; Chen H; Guo Y; Jin F
    Tumour Biol; 2016 Apr; 37(4):4963-72. PubMed ID: 26531722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced miR-125a-5p expression is associated with gastric carcinogenesis through the targeting of E2F3.
    Xu Y; Huang Z; Liu Y
    Mol Med Rep; 2014 Nov; 10(5):2601-8. PubMed ID: 25231560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
    Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
    Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of microRNAs in gastric cancer: a meta-analysis.
    Zhang Y; Guan DH; Bi RX; Xie J; Yang CH; Jiang YH
    Oncotarget; 2017 Aug; 8(33):55489-55510. PubMed ID: 28903436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic and clinicopathological significance of miR-638 in cancer patients: A meta-analysis.
    Hu L; Huang M; Yuan Q; Kong F
    Medicine (Baltimore); 2021 Apr; 100(15):e25441. PubMed ID: 33847647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value and Clinicopathological Features of MicroRNA-206 in Various Cancers: A Meta-Analysis.
    Liu R; Zheng S; Peng S; Yu Y; Fang J; Tan S; Yao F; Guo Z; Shao Y
    Biomed Res Int; 2020; 2020():2159704. PubMed ID: 33145343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of high stanniocalcin 2 expression in solid cancers: A meta-analysis.
    Hu L; Zha Y; Kong F; Pan Y
    Medicine (Baltimore); 2019 Oct; 98(43):e17432. PubMed ID: 31651846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic silenced miR-125a-5p could be self-activated through targeting Suv39H1 in gastric cancer.
    Cai M; Chen Q; Shen J; Lv C; Cai L
    J Cell Mol Med; 2018 Oct; 22(10):4721-4731. PubMed ID: 30117667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer.
    Zhang P; Ji DB; Han HB; Shi YF; Du CZ; Gu J
    World J Gastroenterol; 2014 Sep; 20(34):12241-8. PubMed ID: 25232258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.